Tandem Diabetes Care (TNDM) PT Raised to $27 at Truist Securities
Tweet Send to a Friend
Truist Securities analyst Richard Newitter raised the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $27.00 (from $24.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
